Stockscreener 앱 받기
0.8151
0.32%
-0.0026
시장 영업 전:
.82
0.0049
+0.60%
전일 마감가:
$0.8177
열려 있는:
$0.8051
하루 거래량:
43,478
Relative Volume:
0.23
시가총액:
$42.30M
수익:
$28,000
순이익/손실:
$-14.36M
주가수익비율:
-2.2455
EPS:
-0.363
순현금흐름:
$-11.36M
1주 성능:
-3.88%
1개월 성능:
+3.69%
6개월 성능:
-39.17%
1년 성능:
+61.73%
1일 변동 폭
$0.8051
$0.8476
1주일 범위
$0.77
$0.879
52주 변동 폭
$0.38
$1.57
Talphera Inc Stock (TLPH) Company Profile
명칭
Talphera Inc
전화
650-216-3500
주소
1850 GATEWAY DRIVE, SAN MATEO
Compare TLPH vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.8151 | 42.44M | 28,000 | -14.36M | -11.36M | -0.363 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2020-07-20 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | 재개 | Credit Suisse | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Outperform |
| 2019-04-24 | 재개 | B. Riley FBR | Buy |
| 2019-02-15 | 개시 | Credit Suisse | Outperform |
| 2018-10-23 | 개시 | B. Riley FBR | Buy |
| 2017-10-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-10-13 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-07-14 | 재개 | Jefferies | Buy |
| 2016-09-15 | 재확인 | ROTH Capital | Buy |
| 2016-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2015-10-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2015-10-05 | 재확인 | ROTH Capital | Buy |
| 2015-09-02 | 개시 | H.C. Wainwright | Buy |
| 2015-07-10 | 재개 | ROTH Capital | Buy |
| 2015-05-06 | 재확인 | Mizuho | Neutral |
| 2015-05-05 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-03-10 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-03-09 | 다운그레이드 | Mizuho | Buy → Neutral |
모두보기
Talphera Inc 주식(TLPH)의 최신 뉴스
Talphera Inc. (TLPH) Edges Higher as Shares Test Key Resistance at $0.88Bollinger Expansion - Newser
TALPHERA (TLPH) CMO surrenders 4,518 shares to cover RSU tax - Stock Titan
Talphera Earnings Call Highlights NEPHRO Trial Momentum - The Globe and Mail
TLPH Stock Price, Quote & Chart | TALPHERA INC (NASDAQ:TLPH) - ChartMill
WestPark Capital initiates coverage of Talphera (TLPH) with buy recommendation - MSN
Talphera (TLPH) Amendment: Lytton reports 1.25M shares, 2.5% - Stock Titan
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Talphera Earnings Call Highlights Trial Momentum, Risks - TipRanks
A. G. P. Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3.5 - Moomoo
Talphera, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEF - GuruFocus
How to Value Talphera (TLPH) After Q1 2026 Earnings? EPS: Not Di - GuruFocus
Talphera (TLPH) Q1 2026 Earnings Transcript - AOL.com
TLPHNafamostat Study Enrollment Progress and Financial Update - GuruFocus
Talphera targets Niyad PMA filing in 2026 and potential approval in 2027 as NEPHRO enrollment surpasses 50% - MSN
Talphera, Inc Q1 Net Income From Continuing Operations USD -2.556 Million - TradingView
Talphera Q1 2026 Earnings Call Transcript - Benzinga
TLPH: NEPHRO study enrollment exceeds 50%, with top-line data expected in H2 2026 - TradingView
Earnings call transcript: Talphera Inc Q1 2026 highlights cash position and clinical progress - Investing.com UK
Talphera (NASDAQ: TLPH) posts Q1 2026 loss and flags going concern, Nasdaq risk - Stock Titan
Talphera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Talphera: Q1 Earnings Snapshot - kare11.com
MSN Money - MSN
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ... By GuruFocus - Investing.com Canada
Rosalind-backed holders report 12.9M shares in Talphera (NASDAQ: TLPH) - Stock Titan
Number of shareholders of Talphera, Inc. – NASDAQ:TLPH - TradingView
Talphera Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Is Talphera (TLPH) stock hiding in plain sight? (Smart Money Active) 2026-05-08Reward Analysis - Newser
Talphera (TLPH.US) will release its earnings report after the market closes on May 13. - Moomoo
After the close, Talphera posts Q1 results and holds a 4:30 p.m. ET webcast - Stock Titan
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 - ChartMill
How Talphera (TLPH) revenue breaks down and what it means (Edges Higher) 2026-05-07Stock News - newser.com
TLPH Stock: WestPark Capital Initiates Buy Rating, May 2026 - Meyka
TLPH Initiated Coverage by WestPark Capital -- Rating Set to Buy - GuruFocus
Talphera (NASDAQ: TLPH) seeks approval for equity and ESPP plan changes - Stock Titan
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
AcelRx Pharmaceuticals Q1 2025 Earnings Preview - MSN
Talphera Inc (TLPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Talphera Inc 주식 (TLPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Feb 12 '26 |
Buy |
0.81 |
105,364 |
85,587 |
586,954 |
| Aslam Shakil | Chief Medical Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
83,178 |
| Dasu Badri N | Chief Engineering Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
76,230 |
| ASADORIAN RAFFI | Chief Financial Officer |
Feb 12 '26 |
Buy |
0.81 |
45,000 |
36,554 |
91,256 |
1.92%
4.44%
자본화:
|
볼륨(24시간):